Treating Retinal Disorders: Updates for the Newer Retina Specialist - Live - Miami
Synchronous In-Person Symposium
Thank you for attending. Please click "Take Post-Test" below to proceed to the posttest, evaluation, and claim your credit.
Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous in-person symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.
Overview
Program Overview: It is clear that retina specialists will continue to see an increasing number of patients in the future, as both society ages and as more people develop sight-threatening retina diseases. The need to be fully educated on the various treatment options remains crucial to delivering the best patient care. Further, newer retina specialists must also navigate the business aspects of their clinics. As medical retina clinics are often the busiest departments within eye departments, ensuring efficient patient flow and maintaining high levels of reimbursement are crucial to the success of the department and the clinic.Sponsored by an educational grant from Regeneron Pharmaceuticals, Inc. Learning Objectives
LEARNING OBJECTIVES: Upon completion of this activity, the participant should be able to: • Discuss recent studies that address long-term treatment outcomes in AMD • Develop an individualized treatment plan for patients with AMD • Discuss implementing imaging tools as diagnostic therapies • Summarize the outcomes of pivotal studies in AMD and DME and how study results may differ from “real-world” dosing methods • Summarize the head-to-head-to-head Protocol T findings in DME and how to relate that to clinical practice patterns. • Evaluate practice flow to determine the most efficient patient experience. • Develop plans to reduce reimbursement denials Accreditation
ACCREDITATION STATEMENT Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION STATEMENT Evolve designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
Dilsher S. Dhoot, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alimera Sciences; Allergan plc; Genentech; Notal Vision; Regeneron Pharmaceuticals, Inc . and Santen. Advisory Board/Speaker’s Bureau: Alimera Sciences; Genentech; and Regeneron Pharmaceuticals, Inc. Nathan Steinle, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alimera Sciences;Genentech; Notal Vision; and Vortex Surgery. Advisory Board/Speaker’s Bureau: Genentech; and Regeneron Pharmaceuticals, Inc. Grant/Research Support: Carl Zeiss Meditec; Genentech; and Regeneron Pharmaceuticals, Inc. Rishi P. Singh, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Carl Zeiss Meditec; Genentech, Inc; Optos plc; and Regeneron Pharmaceuticals, Inc. Grant/Research Support: Apellis Pharmaceuticals; Clearside Biomedical; Genentech, Inc; Novartis AG; and Regeneron Pharmaceuticals, Inc.Editorial Support Disclosures Erin K. Fletcher, MIT, director of compliance and education, Evolve; and Michelle Dalton, writer, have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has no financial relationships with commercial interests.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
Off-Label Statement This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, or Regeneron Pharmaceuticals Inc. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Roger A. Goldberg, MD, MBA
Christina Y. Weng, MD, MBA, FASRS
Christina Y. Weng, MD, MBA, FASRS
Katherine E. Talcott, MD
Katherine E. Talcott, MD
Roger A. Goldberg, MD, MBA
